Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMedical Marijuana I

Medical Marijuana I

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0001 USD -0.00 ( 50.00%)
Last update at 2026-11-05T21:00:00Z
VOLUME
22200
Market Cap
2.78M

Momentum Score

…

Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Medical Marijuana, Inc. (MJNA.US) is an OTC-listed holding company that invests in and distributes hemp- and cannabinoid-related consumer products through subsidiaries and affiliates. Long-term growth could be supported by expanding consumer acceptance of CBD, potential easing of regulations, and rising international demand, which may benefit companies with diversified exposure to the sector. Investors may find it attractive as low-cost exposure to the hemp/CBD market.

Key risks include limited disclosure, OTC Pink listing with low liquidity, regulatory and legal uncertainty in cannabis/hemp markets, competitive pressures, and potential dilution or unprofitable operations.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
58.98M
Revenue Per Share
0.01
Gross Profit TTM
46.48M
Debt / Equity
0.05
ROE
12.06%
Net Debt
1.76M
ROCE
-1.49%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.94M -0.64M -5.08M -15.35M -4.77M
Net income -0.94M -0.64M -5.08M -15.35M -4.77M
Gross profit 9.07M 11.66M 11.25M 18.46M 26.86M
Ebit -0.91M -0.35M -4.97M -15.30M -4.52M
Ebitda -0.72M -0.07M -4.72M -14.94M -4.04M
Depreciation and amortization 0.19M 0.27M 0.25M 0.35M 0.48M
Operating income -0.91M -0.00M -4.49M -4.70M -1.78M
Other operating expenses 13.36M 14.91M 21.30M 29.80M 35.90M
Interest expense 0.23M 0.29M 0.12M 0.05M 0.25M
Income tax expense - - -0.00M -0.00M -
Total revenue 12.46M 14.91M 16.81M 25.10M 34.12M
Total operating expenses 9.98M 11.66M 15.74M 23.16M 28.64M
Cost of revenue 3.39M 3.25M 5.57M 6.64M 7.26M
Total other income expense net -0.03M -0.64M -0.59M -10.65M -2.99M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 66.31M 67.83M 69.55M 68.92M 80.72M
Intangible assets 6.61M 6.60M 6.61M - -
Other current assets 1.16M 0.98M 1.32M 2.13M 1.50M
Total liab 16.53M 18.03M 19.63M 14.32M 11.58M
Total stockholder equity 49.78M 49.80M 49.92M 54.60M 69.13M
Other current liab 3.53M 3.90M 4.10M 3.82M 4.46M
Common stock 0.13M 0.08M 0.06M 46.32M 45.57M
Retained earnings -160.51M -159.58M -158.94M -153.85M -138.61M
Good will 45.37M 45.37M 45.37M 45.37M 45.37M
Other assets - - 0.00M - -
Cash 0.75M 1.03M 0.67M 0.74M 5.43M
Total current liabilities 5.48M 6.32M 6.73M 6.67M 6.78M
Net debt 1.76M 1.81M 3.03M 6.92M -0.62M
Short long term debt total 2.51M 2.85M 3.70M 7.65M 4.80M
Other stockholder equity 210.16M 209.30M 208.86M 208.44M 207.73M
Total current assets 4.03M 4.28M 5.35M 9.43M 17.48M
Short term investments - - - - 0.03M
Net receivables 0.90M 0.99M 1.57M 4.11M 7.84M
Inventory 1.22M 1.28M 1.79M 2.45M 2.68M
Accounts payable 1.95M 2.42M 2.63M 2.85M 2.32M
Accumulated other comprehensive income - - -0.06M -46.32M -45.57M
Non currrent assets other - 0.00M 6.61M 0.20M 0.20M
Non current assets total 62.28M 63.55M 64.20M 59.49M 63.24M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities 0.06M 0.41M -2.67M 6.17M 1.86M
Total cash from financing activities 1.01M -0.38M 5.15M 3.89M 1.77M
Net income -0.94M -0.64M -5.08M -15.35M -4.77M
Change in cash -0.28M 0.36M -0.06M -4.69M -0.85M
Begin period cash flow 1.03M 0.67M 0.74M 5.43M 6.27M
End period cash flow 0.75M 1.03M 0.67M 0.74M 5.43M
Total cash from operating activities -1.35M 0.98M -2.54M -14.75M -4.48M
Depreciation 0.19M 0.27M 0.25M 0.35M 0.48M
Other cashflows from investing activities - - -0.00M 0.00M -
Dividends paid - - - - 0.11M
Change to inventory 0.05M 0.51M 0.66M -0.60M 1.21M
Change to account receivables 0.09M -0.01M 0.47M 0.86M -0.10M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities -0.31M -0.34M -2.67M 0.10M 0.10M
Capital expenditures 0.00M 0.00M 4.36M 2.86M 0.02M
Change in working capital -0.61M 0.70M 2.29M -0.59M 0.04M
Stock based compensation - - - - -0.93M
Other non cash items - 0.64M -0.42M 0.83M 0.45M
Free cash flow -1.35M 0.98M -6.90M -17.61M -4.50M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MJNA
Medical Marijuana I		 -0.00
50.00%		 0.00 - - 0.05 0.59 1.87 -0.23
MKKGY
Merck KGaA ADR		 -0.22
0.66%		 33.17 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.17
0.80%		 21.02 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

Medical Marijuana I

Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, California.

2384 La Mirada Drive, Vista, CA, United States, 92081

866 273 8502

https://www.medicalmarijuanainc.com

91

Name Title Year Born
Mr. Blake N. Schroeder Esq. Chairman & CEO 1976
Mr. Todd Morrow Pres NA
Mr. Dirk Syburra VP of Data & Technology NA
Mr. Tyler Whatcott Chief Technology Officer NA
Ms. Michelle L. Sides Esq. Chief Legal Officer & Director NA
Chuck Smith Chief Operating Officer of Red Dice Holdings NA
Dr. Rubens Wajnsztejn Chief Medical Officer NA
Dr. George E. Anastassov DDS, M.D., MBA Member of Advisory Board and Chief Exec. Officer of Canchew Biotechnologies 1963
Dr. Timothy Richard Scott Ph.D. CEO, President & Chairman 1953
Ms. Michelle L. Sides Esq. Chief Legal Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…